Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  mercaptopurine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 282 for your search:
Start Over
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL03, NCT00199004
Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 0 to 75
Sponsor: Other
Protocol IDs: LPA 2005, NCT00408278
PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 and over
Sponsor: Other
Protocol IDs: LAL-RI/96, NCT00494897
LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 16 and under
Sponsor: Other
Protocol IDs: LAL-AR-N-2005, NCT00526409
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: Other
Protocol IDs: GMALL04, NCT00199017
Rituximab Plus Chemotherapy for CD20+ Adult Acute Lymphoblastic Leukemia
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: RJ-2010-56, NCT01358253
Phase II-III VCR/PRED/L-ASP Induction, CNS Therapy plus MTX vs 6-MP/MTX vs 6-MP/MTX/CTX vs 6-MP/MTX/CTX/ARA-C for Pediatric ALL
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 18
Sponsor:
Protocol IDs: SJCRH-ALL-TT-8
Phase II/III Randomized Study of Standard-Dose vs High-Dose MTX Followed by Induction and Continuation for Patients with ALL or AUL
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-81001, NCI-D82-018-0400, D82-018-0400
Phase II/III Randomized Comparison of Up-Front Alternating Chemotherapy vs Up-Front Intensive 6-MP/MTX for Poor Prognosis Childhood ALL
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 1 to 20
Sponsor: NCI
Protocol IDs: POG-8698
Phase I/III Induction with ADR/ARA-C/VCR/PRDL and Consolidation and Maintenance with ADR/ARA-C, ADR/AZC, MePRDL/VCR/6-MP/MTX, or ARA-C for ANLL
Phase: Phase III, Phase I
Type: Treatment
Status: Closed
Age: under 50
Sponsor:
Protocol IDs: DFCI-76006, DFCI-VAPA-10
Phase III Randomized Study of Twice-Daily vs Standard Daily MP During Continuation Therapy in Children with Standard-Risk Acute Lymphocytic Leukemia: An ALinC #16 Study
Phase: Phase III
Type: Treatment
Status: Closed
Age: 1 through 21 at diagnosis
Sponsor: NCI
Protocol IDs: POG-9405, POG-ALINC-16/SR
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 22
Sponsor: NCI, Other
Protocol IDs: 9315, POG-9315, CDR0000063955, NCT00002618
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 60
Sponsor: Other
Protocol IDs: EORTC-06951, FRE-LALA-94, NCT00002700
Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 0 to 21
Sponsor: NCI, Other
Protocol IDs: 9404, U10CA030969, POG-9404, CDR0000064664, NCT01230983
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 9
Sponsor: NCI, Other
Protocol IDs: 1952, CCG-1952, CDR0000064665, NCT00002744
Phase III Randomized Study of Unrelated Donor BMT vs Continuing Chemotherapy for Childhood Acute Lymphoblastic Leukemia in First Relapse
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039
Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 96-015, P30CA008748, MSKCC-96015A1, NCI-V96-0881, NCT00002766
Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: 1961, CCG-1961, CDR0000064953, NCT00002812
Start Over